Definitive Contract 75F40121C00184
Award Date
9/22/21
Potential Completion Date
9/29/22
Potential Value
$250K
Federal Agency
Food and Drug Administration
Awardee
Hartford Hospital
Ultimate Awardee
Hartford Healthcare Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded a Firm Fixed Price Definitive Contract to Hartford Hospital, a non-profit hospital in Hartford, Connecticut, with a potential value of $249,794.00. The contract is for research related to "Metallo-B-Lactamase Resistance in Enterobacterales: Is It Time to Rethink Our In Vitro Assessment Tools?". This contract was issued under a Broad Agency Announcement (BAA) that solicits advanced research and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $248,725 Firm Fixed Price contract to Hartford Hospital, a non-profit 830-bed hospital in Hartford, Connecticut. The contract was awarded under the FDA's Broad Agency Announcement (BAA) seeking advanced research and development proposals to support regulatory science and innovation across multiple areas. Under this contract, Hartford Hospital is conducting comparative efficacy research on antibiotic...
This is a definitive contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Hartford Hospital, a non-profit hospital located in Hartford, Connecticut. The contract, with a potential value of $249,991.00, is for research on the pharmacodynamics of three antibiotics - minocycline, levofloxacin, and trimethoprim/sulfamethoxazole - against the bacterium Stenotrophomonas maltophilia. The goal of the research is to provide data to support potential...
Yale University was awarded a definitive cost-no-fee contract valued at $3.3 million by the Department of Health and Human Services Food and Drug Administration to support the agency's Broad Agency Announcement for Advanced Research and Development of Regulatory Science. The prime contractor will leverage community engagement and electronic health record strategies to promote diverse participation in COVID-19 clinical trials, addressing Research Area 9 under the BAA which seeks proposals to...
The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation. Under the contract, Brigham & Women's Hospital is working closely with the FDA's...
The Department of Health and Human Services Food and Drug Administration awarded a $3.1 million definitive contract to St. Jude Children's Research Hospital Inc. to conduct modeling of pediatric solid tumors and the tumor microenvironment. This contract was awarded under the agency's fiscal year 2021 Broad Agency Announcement for Advanced Regulatory Science, which sought proposals across eight areas of regulatory science including strengthening social and behavioral research. There was no...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to the Universitat ST. Gallen, doing business as Hochschule FÜR Wirtschafts-, Rechts- UND Sozialwissenschaften (Hsg), an educational institution. The contract is a Firm Fixed Price definitive contract with a potential value of $764,418.19 and a completion date of September 29, 2023. The contract was awarded under the FDA's Broad Agency Announcement (BAA) for Advanced Regulatory...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $21,750 purchase order to Howard University for research services. The firm fixed price contract has a period of performance from April 2017 to April 2019. As the prime contractor, Howard University will perform the research services out of its division located in Silver Spring, Maryland. No additional details were provided regarding the scope of work, but the FDA funds various clinical trials and...
The Department of Health and Human Services Food and Drug Administration awarded a $2,963,836.42 firm fixed price delivery order contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract supports developing capability to use Medicaid data for FDA post-market drug safety surveillance during pregnancy. This contract is a task order under the FDA's Scientific Pharmacoepidemiologic Research Program, a larger...
The University of Connecticut (UConn) has been awarded a $1,103,886 firm-fixed-price definitive federal contract by the Food and Drug Administration (FDA) for research and development related to the impact of active pharmaceutical ingredients on in situ forming implants and understanding in vitro and in vivo performance differences. This contract, which has a completion date of September 29, 2026, was issued under the FDA's Broad Agency Announcement for research and development to support...